| P2093 | author name string | Dan Chen | |
| | Hong Tang | |
| | Kai Yang | |
| | Dan Zhao | |
| | Ningbo Zhao | |
| | Chunrong Zhao | |
| | Genling Yang | |
| P2860 | cites work | A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. | Q51644321 |
| | Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. | Q52563371 |
| | Altered expression of circadian clock genes in human chronic myeloid leukemia. | Q52609598 |
| | Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. | Q53288026 |
| | Abnormal expression of period 1 (PER1) in endometrial carcinoma. | Q54672332 |
| | Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis | Q75403000 |
| | A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway | Q21562478 |
| | The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo | Q28206180 |
| | The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation | Q28261349 |
| | Molecular characterization of Mybbp1a as a co-repressor on the Period2 promoter | Q28512569 |
| | Daily timed meals dissociate circadian rhythms in hepatoma and healthy host liver | Q30438418 |
| | Circadian oscillation of nucleotide excision repair in mammalian brain | Q33402391 |
| | Recent advances in the regulation of matrix metalloproteinase 2 activation: from basic research to clinical implication (Review). | Q34124100 |
| | The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells | Q34522359 |
| | The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. | Q35013139 |
| | Genetic clock of biologic rhythms. | Q35644651 |
| | Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases | Q35842142 |
| | Chronobiology, drug delivery, and chronotherapeutics | Q36947532 |
| | Global epidemiology of oral and oropharyngeal cancer | Q37274268 |
| | A role for the clock gene per1 in prostate cancer | Q37373255 |
| | Metabolism and cancer: the circadian clock connection | Q37638137 |
| | Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways | Q37680313 |
| | Chronotherapy and the molecular clock: Clinical implications in oncology. | Q37769867 |
| | PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells | Q39813356 |
| | Circadian Expression of Clock- and Tumor Suppressor Genes in Human Oral Mucosa | Q39843632 |
| | Physiology of the circadian system in animals and humans | Q41298591 |
| | Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer. | Q46743558 |
| | Altered expression of circadian clock genes in head and neck squamous cell carcinoma | Q48274145 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e55894 | |
| P577 | publication date | 2013-02-06 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Aberrant expression of clock gene period1 and its correlations with the growth, proliferation and metastasis of buccal squamous cell carcinoma | |
| P478 | volume | 8 | |